Study of INT-747 in Patients With Diabetes and Presumed NAFLD

Clinical trial NCT00501592 · COMPLETED

Trial details

NCT number: NCT00501592
Sponsor: Intercept Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type II Fatty Liver

Start date: 2007-07-01
Primary completion: 2009-02-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.